Please login to the form below

Not currently logged in

NHS test and trace system ‘still not good enough’ says health leader


Test and trace system falls short in latest figures

Spending by pharma on UK R&D increased last year

ABPI London officesData shows third annual increase in a row

Cancer research funding could be cut due to COVID-19 pandemic

Cancer Research UK logoCharity warns £150m could be lost per year

New cancer blood test proves more sensitive than current diagnostic methods

Cancer Research UK logoTest could be up to ten times more sensitive than standard methods

FDA pulls emergency OK for hydroxychloroquine in COVID-19

FDA headquarters White OakData shows drug may reduce effectiveness of remdesivir

Sinovac reveals positive preliminary data for COVID-19 vaccine

Coronavirus vaccinePlans protocol application for phase 3 study

bluebird set for 2021 filing for sickle cell gene therapy LentiGlobin

Bluebird BioGene therapy was approved last year as Zynteglo for beta thalassaemia

After industry lobbying, UK agrees to top up Biomedical Catalyst

LondonNews of funding comes after 40% decline in biotech funding in 2019

COVID-19 round-up: medicines on trial

Interim analysis clinical trialsNew drugs starting clinical testing in COVID-19 patients, plus clinical results and regulatory filings

EU flag bodyWho's calling the shots in European healthcare?

Patients versus Pharma: industry too powerful, and too cosy with EMA, says Yannis Natsis

COVID-19 Updates and Daily News

Featured jobs


Add my company

Hamell is a full-service agency with a clear focus on delivering evidence-based, sustained behaviour change. So, whether you are looking...

Latest intelligence

The search for treatments for Parkinson’s disease
The research requires resilience but pharma is urged to ‘keep innovating, keep trying’...
Margot Hannah, OPEN Health - A personal perspective of LGBT+ and diversity.
Ditch the Label – it’s just me....
The impact of COVID-19 on clinical trials
As all industry sectors work to assess both the impact and the optimal path forward, the effects are expected to be diverse and long-lasting...